Loading
A phase 1/2 trial of fluorouracil (5-FU), gemcitabine, fOLFIRI (5-FU, leucovorin, irinotecan), leucovorin (folinic acid) and other drugs in pancreatic cancer, run by Ohio State University Comprehensive Cancer Center, not yet recruiting.
DCE-MRI for Neoadjuvant Treatment Assessment in Patients With Borderline Resectable Pancreatic Cancer is a phase 1/2, interventional study registered as NCT07705919 by Ohio State University Comprehensive Cancer Center, with a registry enrolment figure of 50 participants, started 2026-09-01 and due to reach its primary completion in 2027-12-31. Interventions recorded: Biospecimen Collection; Computed Tomography; Dynamic Contrast-Enhanced Magnetic Resonance Imaging; Fluorouracil; Gadolinium-Chelate; Gemcitabine; Irinotecan; Leucovorin Calcium; Nab-paclitaxel; Oxaliplatin; Point-of-care portable perfusion phantom (P4). Conditions listed: Borderline Resectable Pancreatic Ductal Adenocarcinoma. Primary outcome: R0 resection rate. Pancreatic eligibility wording from the registry: "* Histological or cytological evidence of pancreatic adenocarcinoma". Sites: United States. No results are recorded here; the registry entry is the source.
Shares FOLFIRI (5-FU, leucovorin, irinotecan), CAPOX (capecitabine, oxaliplatin), Borderline resectable pancreatic ductal adenocarcinoma, Nab-paclitaxel and the tag pancreatic-deep-dive.
Shares FOLFIRI (5-FU, leucovorin, irinotecan), Leucovorin (folinic acid), CAPOX (capecitabine, oxaliplatin), Fluorouracil (5-FU) and the tag pancreatic-deep-dive.
Shares Borderline resectable pancreatic ductal adenocarcinoma, Nab-paclitaxel, Resectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites) and the tag pancreatic-deep-dive.
Shares Leucovorin (folinic acid), CAPOX (capecitabine, oxaliplatin), Fluorouracil (5-FU), Resectable pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares FOLFIRI (5-FU, leucovorin, irinotecan), CAPOX (capecitabine, oxaliplatin), Nab-paclitaxel, Fluorouracil (5-FU) and the tag pancreatic-deep-dive.
Shares FOLFIRI (5-FU, leucovorin, irinotecan), CAPOX (capecitabine, oxaliplatin), Nab-paclitaxel, Fluorouracil (5-FU) and the tag pancreatic-deep-dive.
Shares Borderline resectable pancreatic ductal adenocarcinoma, Nab-paclitaxel, Resectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites) and the tag pancreatic-deep-dive.
Shares Leucovorin (folinic acid), CAPOX (capecitabine, oxaliplatin), Fluorouracil (5-FU), Resectable pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.